Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
Executive Summary
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.
Further Reading
Haleon Surprises Analysts With Stand-Out Cold & Flu Showing In Q4
Kenvue Prioritizes Growing 15 Brands In Pivot To Recovering Marketplace Prominence
Sanofi Consumer Healthcare Separation: Four Talking Points
Bayer To Hold On To Consumer Health While It Deals With More Pressing Issues
Further Listening
Over The Counter 22 November 2021: CHC Spin Outs, Supply Chain Issues And Other Q3 Trends
Citeline podcasts are available on Apple Podcasts, Google Podcasts, SoundCloud and TuneIn - and also now on Spotify Podcasts - and via smart speakers if one of these platforms has been set up as your default podcast provider.
Over The Counter Theme Music:
Warm Vacuum Tube by Admiral Bob (c)
Copyright 2019 Licensed under a Creative Commons Attribution (3.0) license